Dylan Morris
InvestorManaging Director at Insight Partners · Board director at Deciduous Therapeutics
San Francisco Bay Area
Writes $10M – $350M checks · typically $25M
Find your path to Dylan
509 people in our graph share verified history with Dylan — schools, employers, funds. One of them is your warm intro.
Avi BharadwajunlockedDylan: together at Innovation Endeavors (2017)
×9Dylan: together at Insight Partners
Dylan: together at Unlearn
Dylan: together at Plexium
About
Dylan Morris, a computational biologist who modeled immune cells across biochemistry and computer science, leads a software-first bio practice focused on computational biology, tech-enabled drug discovery and ending involuntary dying.
Invests in
AI & Machine LearningCybersecurityFintechFuture of WorkHealthtech
Board director at Deciduous Therapeutics
Intro paths
→
In turn, Dylan can intro founders to Deciduous Therapeutics's investors below.
Deciduous Therapeutics's investors · 8
age1San Francisco · $500K – $4M checks · since 2019Axial VCSan Francisco · $100K – $5M checks · since 2019Bold Capital PartnersSanta Monica · since 2019Cornucopian Capital ManagementMontclair · since 2019CRV (Charles River Ventures)Bay Area · $250K – $5M checks · since 2019Mana VenturesEstero · since 2019Owl Capitalsince 2019quadraScope Venture FundBoston · since 2019
Co-founders at Deciduous Therapeutics
RM
Robin MansukhaniCEO and Co-Founder
AB
Anil BhushanScientific Founder
Experience
- Insight PartnersManaging Directorcurrent2021 — present
- PhaseVBoard Directorcurrent2025 — present
- Averna TherapeuticsBoard Directorcurrent2024 — present
- Superluminal Medicines Inc.Board Directorcurrent2023 — present
- ImmuneBridgeBoard Directorcurrent2023 — present
- Profluent BioBoard Directorcurrent2022 — present
- Unlearn.AIBoard Directorcurrent2022 — present
- DEM Biopharma, Inc.Board Directorcurrent2022 — present
- ArrePathBoard Directorcurrent2021 — present
- Switch TherapeuticsBoard Directorcurrent2020 — present
- Deciduous TherapeuticsBoard Directorcurrent2019 — present
- Exo TherapeuticsBoard Observercurrent2019 — present
- Dyno TherapeuticsBoard Directorcurrent2018 — present
- PlexiumBoard Observercurrent2018 — present
- GametoBoard Director2022 — 2024
- CRVGeneral Partner2017 — 2021
- Innovation EndeavorsInvestment Team2015 — 2017
- Integrated Plasmonics CorporationCo-Founder2011 — 2014
Skills & more
Entrepreneurship30R&D17Nanotechnology29Start-ups35Python8Biotechnology28Venture Capital6Biomedical Engineering5Science4Molecular Biology4Data Analysis2Mathematica1
+8 more
Product DevelopmentMedical DevicesMatlabIntegrated MarketingBioinformaticsStrategyLifesciencesGenomicsFrom Dylan's professional profile.
Colleagues at Insight Partners
Aayush Setty
Analyst at Insight Partners
Abdi Adan
Investor at Insight Partners
Adam Berger
Managing Director at Insight Partners
Adam Domingoes
Senior Associate at Insight Partners
Adam Vartabedian
Investor at Insight Partners
Aidan Waldman
Investor at Insight Partners
Aiden Aceves
Vice President at Insight Partners
AJ Malhotra
Managing Director at Insight Partners
Network7
Jeff HoringScout
Co-founder & Managing Director at Insight Partners
George MathewScout
Managing Director at Insight Partners
Hagi SchwartzScout
LP Advisory Board at Fusion VC
Aayush Setty
Analyst at Insight Partners
Abdi Adan
Investor at Insight Partners
Adam Berger
Managing Director at Insight Partners
Adam Domingoes
Senior Associate at Insight Partners
Investors connected to Dylan in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Dylan Morris?
- Dylan Morris, a computational biologist who modeled immune cells across biochemistry and computer science, leads a software-first bio practice focused on computational biology, tech-enabled drug discovery and ending involuntary dying.
- Where does Dylan Morris work?
- Dylan Morris is Managing Director at Insight Partners and Board director at Deciduous Therapeutics.
- What does Dylan Morris invest in?
- Dylan Morris invests in AI & Machine Learning, Cybersecurity, Fintech, Future of Work, Healthtech.
- What check size does Dylan Morris write?
- Dylan Morris typically writes checks of $10M – $350M.
- Where did Dylan Morris go to school?
- Dylan Morris studied at Caltech (Graduate Research, Biochemistry and Molecular Biophysics); Harvard University (AB, Computer Science).
Same school
Also attended Caltech231
Shaun MaguirePartner at Sequoia CapitalDario AmodeiCo-founder & CEO of AnthropicFei-Fei LiCo-founder & CEO of World Labs; Sequoia Professor of Computer Science at StanfordScott BillerInvestor at GV (Google Ventures)Seth LieblichInvestment Team at 8VCSusannah BarbeeVice President, Translational Immunology at Deerfield Management Company
+ 225 more
Also attended Harvard University2,000
Ron ConwayFounder of SV AngelAlfred LinPartner at Sequoia CapitalChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzSarah TavelVenture Partner at BenchmarkDanny RimerPartner at Index VenturesLaela SturdyManaging Partner at CapitalG
+ 1,994 more
Shared employers
Also worked at Averna Therapeutics5
Also worked at Unlearn.AI7
Francisco GimenezInvestment Team at 8VCMegh GuptaPartner at Wittington VenturesEli ScottAssociate at Wittington VenturesJulia CoelhoAdvisor - Business Development at Kicker VenturesAngela DaoFounder at StellarAaron SmithFounder at Unlearn
+ 1 more
Also worked at Dyno Therapeutics8
Yousuf ShehadiTalent at AudaciousJorge CondeGeneral Partner at Andreessen HorowitzAndy TranPrincipal at Matrix Capital ManagementAndrés RosalesCo-Founder & Co-CEO at PrimeroEric KelsicCEO & Cofounder at Dyno TherapeuticsGeorge ChurchScientific Advisor / Co-Founder at Eugit Therapeutics
+ 2 more
Also worked at CRV63
Ann Miura-KoCo-founding Partner at FloodgateBruce SachsInvestor at CRV (Charles River Ventures)Mike ZakInvestor at CRV (Charles River Ventures)Rick BurnesInvestor at CRV (Charles River Ventures)Santo PolitiInvestor at Spark CapitalAnnie KadavyVenture Partner at Redpoint Ventures
+ 57 more